Biotech M&A Booms, But Have We Reached A Tipping Point?
Gregory Renza, M.D., Senior Biotechnology Analyst, delves into the driving forces behind the recent surge of...
Listen (16m) | When to Call it Quits: VCs Making Tough Decisions in a Tough Market
RBC’s Noël Brown, Head of US Biotechnology Investment Banking, recently held an Endpoints roundtable with...
The Power and Potential of Genetic Medicine
Genetic medicine is poised to unlock more value for patients and investors. RBC’s biotechnology analyst Luca...
The Competitive Landscape of Gene Therapy and Immuno-oncology
The road is paved for gene therapy and immuno-oncology treatment innovation in 2023 as emerging clinical...
Read (5m) | ViewThe Hidden Revolution Set to Turn US Healthcare on its Head
In this episode of Pathfinders, RBC’s Healthcare Technology Analyst Sean Dodge discusses the value-based...
The Big Picture for Biotech
In this latest episode, our head of biotech research Brian Abrahams shares a big picture analysis of the...
Pathfinders in Biopharma Podcast
Our podcast series explores the fast-moving world of biopharma and what the road ahead looks like for companies and investors in the sector.
More Healthcare insights
From biotech breakthroughs to digital transformation, our global healthcare specialists dive deep into the latest trends, innovations, and emerging opportunities.
Stay Informed
Get the latest insights from RBC Capital Markets delivered to your inbox.